Information message

In order to see all the search results and access content, you must log in. Please use the Log-in button at the top of the page.

Displaying 157 - 168 of 440
Immune-Mediated and Cholestatic Diseases
Online Course: Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection

Online Course: Role of the IgG4-related cholangitis autoantigen annexin A11 in cholangiocyte protection

Online Courses
View
Metabolism, Alcohol & Toxicity
Online course: Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease

Online course: Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease

Online Courses
View
General Hepatology
Online course: EASL–EFSUMB Ultrasound of the liver

Online course: EASL–EFSUMB Ultrasound of the liver

Online Courses
View
Basic Science
Basic Techniques in Experimental Hepatology at a Glance

Basic Techniques in Experimental Hepatology at a Glance

Basic Techniques in Experimental Hepatology at a Glance
View
Metabolism, Alcohol & Toxicity
EASL Studio Podcast S4 E23: The conundrum of NASH: The growing global disease burden with low disease awareness

EASL Studio Podcast S4 E23: The conundrum of NASH: The growing global disease burden with low disease awareness

Podcasts
View
Liver Tumours
Quiz: A female of 70 years all with type II diabetes, hypertension and NASH

Quiz: A female of 70 years all with type II diabetes, hypertension and NASH

Quiz
View
General Hepatology
Online course: EASL–ESPEN Nutrition in liver disease

Online course: EASL–ESPEN Nutrition in liver disease

Online Courses
View
General Hepatology
EASL YI Afterwork Series: Live(r) webinar – Ready for ILC 2022

EASL YI Afterwork Series: Live(r) webinar – Ready for ILC 2022

On-demand Webinars
View
Metabolism, Alcohol & Toxicity
EASL Studio Podcast S4 E22: JHEP Live: New and promising drugs for NASH on the horizon

EASL Studio Podcast S4 E22: JHEP Live: New and promising drugs for NASH on the horizon

Podcasts
View
General Hepatology
EASL Studio Podcast S4 E21: Why you should stop smoking if you love your liver

EASL Studio Podcast S4 E21: Why you should stop smoking if you love your liver

Podcasts
View
Metabolism, Alcohol & Toxicity
Quiz: A quarter of the global adult population is estimated to have non-alcoholic fatty liver disease (NAFLD)

Quiz: A quarter of the global adult population is estimated to have non-alcoholic fatty liver disease (NAFLD)

Quiz
View

EASL Studio S4 E20: COST Actions: Opportunities for pan-European collaborations in liver diseases

Description

Collaborations are key in achieving scientific progress. The European Horizon COST Actions provide great opportunities to build, grant, and/or participate in pan-European collaborations in multidisciplinary topics, including liver diseases.

This EASL Studio:

  • Provides you with information about the COST Action programme.
  • Discusses the structure of the drug-induced liver injury (DILI) and cholangiocarcinoma (CCA) working groups.
  • Highlights the potential for collaborative work within this programme.

Faculty

  • Prof. Jesús Bañales (Moderator)
  • Prof. Raul Andrade (Faculty)
  • Dr Chiara Braconi (Faculty)
  • Prof. Vincenzo Cardinale (Faculty)

Related episodes

  • S4E13: EASL-EF CLIF and EU Grants: Exploring novel mechanisms and treatment of chronic liver failure
  • S4E2: YI Choice: How to build consortia and registries

ℹ️ Please click here to access the podcast version of this EASL Studio episode.

 

Log in to post comments
Displaying 157 - 168 of 440